[go: up one dir, main page]

PL340837A1 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
PL340837A1
PL340837A1 PL98340837A PL34083798A PL340837A1 PL 340837 A1 PL340837 A1 PL 340837A1 PL 98340837 A PL98340837 A PL 98340837A PL 34083798 A PL34083798 A PL 34083798A PL 340837 A1 PL340837 A1 PL 340837A1
Authority
PL
Poland
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
PL98340837A
Inventor
Andrew Baxter
David Cheshire
Thomas Mcinally
Michael Mortimore
David Cladingboel
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of PL340837A1 publication Critical patent/PL340837A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PL98340837A 1997-12-05 1998-12-01 Novel compounds PL340837A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704546A SE9704546D0 (en) 1997-12-05 1997-12-05 Novel compounds

Publications (1)

Publication Number Publication Date
PL340837A1 true PL340837A1 (en) 2001-02-26

Family

ID=20409283

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98340837A PL340837A1 (en) 1997-12-05 1998-12-01 Novel compounds

Country Status (16)

Country Link
EP (1) EP1037889A1 (en)
JP (1) JP2001525406A (en)
KR (1) KR20010032800A (en)
CN (1) CN1284074A (en)
AU (1) AU1791599A (en)
BR (1) BR9813378A (en)
CA (1) CA2312357A1 (en)
EE (1) EE200000321A (en)
HU (1) HUP0100731A3 (en)
IL (1) IL136368A0 (en)
NO (1) NO20002787L (en)
PL (1) PL340837A1 (en)
SE (1) SE9704546D0 (en)
SK (1) SK8442000A3 (en)
TR (1) TR200001544T2 (en)
WO (1) WO1999029686A1 (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9901875D0 (en) 1999-05-25 1999-05-25 Astra Pharma Prod Novel compounds
SE9904505D0 (en) 1999-12-09 1999-12-09 Astra Pharma Prod Novel compounds
TWI258462B (en) 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
SE9904652D0 (en) * 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
JP2002330787A (en) * 2000-10-21 2002-11-19 Astrazeneca Ab Chemical substance
WO2003042190A1 (en) 2001-11-12 2003-05-22 Pfizer Products Inc. N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
PA8557501A1 (en) 2001-11-12 2003-06-30 Pfizer Prod Inc BENZAMIDA, HETEROARILAMIDA AND INVESTED AMIDAS
PA8591801A1 (en) 2002-12-31 2004-07-26 Pfizer Prod Inc BENZAMID INHIBITORS OF THE P2X7 RECEIVER.
US7071223B1 (en) 2002-12-31 2006-07-04 Pfizer, Inc. Benzamide inhibitors of the P2X7 receptor
CA2525437C (en) 2003-05-12 2009-04-28 Pfizer Products Inc. Benzamide inhibitors of the p2x7 receptor
GB0324498D0 (en) 2003-07-21 2003-11-26 Aventis Pharma Inc Heterocyclic compounds as P2X7 ion channel blockers
MXPA06014022A (en) 2004-06-29 2007-02-08 Pfizer Prod Inc Methods for preparing p2x7 inhibitors.
ES2569677T3 (en) 2006-03-16 2016-05-12 Second Genome, Inc. Bicycloheteroaryl compounds as modulators of P2X7 and uses thereof
US8779144B2 (en) 2006-03-16 2014-07-15 Evotec (Us) Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
TWI464148B (en) 2006-03-16 2014-12-11 Evotec Us Inc Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
TW200813018A (en) 2006-06-09 2008-03-16 Astrazeneca Ab Novel compounds
US7718693B2 (en) 2006-07-06 2010-05-18 Glaxo Group Limited Receptor antagonists and their methods of use
GB0613473D0 (en) * 2006-07-06 2006-08-16 Glaxo Group Ltd Novel compounds
US8093265B2 (en) 2007-03-09 2012-01-10 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
WO2008116845A1 (en) * 2007-03-28 2008-10-02 Glaxo Group Limited Piperidinone carboxamide derivatives as p2x7 modulators
EP2139875A2 (en) * 2007-03-29 2010-01-06 Glaxo Group Limited Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators
KR20090127435A (en) * 2007-04-03 2009-12-11 글락소 그룹 리미티드 Imidazolidine Carboxamide Derivatives as P2X7 Modulators
US8119661B2 (en) 2007-09-11 2012-02-21 Astrazeneca Ab Piperidine derivatives and their use as muscarinic receptor modulators
GB0803729D0 (en) * 2008-02-29 2008-04-09 Ge Healthcare Ltd Imaging the central nervous system
NZ587799A (en) 2008-03-25 2012-06-29 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
ES2380908T3 (en) 2009-04-14 2012-05-21 Affectis Pharmaceuticals Ag Novelty p2x7r antagonists and their use
EP2322149A1 (en) 2009-11-03 2011-05-18 Universidad del Pais Vasco Methods and compositions for the treatment of ischemia
AU2011252351A1 (en) 2010-05-14 2012-10-11 Affectis Pharmaceuticals Ag Novel methods for the preparation of P2X7R antagonists
WO2012110190A1 (en) 2011-02-17 2012-08-23 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163792A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2012163456A1 (en) 2011-05-27 2012-12-06 Affectis Pharmaceuticals Ag Novel p2x7r antagonists and their use
WO2019102354A1 (en) 2017-11-21 2019-05-31 3M Innovative Properties Company Oral plant-based-oil-in-water emulsions and methods of use
WO2019123261A2 (en) 2017-12-20 2019-06-27 3M Innovative Properties Company Oral compositions and methods of use
CN111511362A (en) 2017-12-20 2020-08-07 3M创新有限公司 Oral compositions and methods of use

Also Published As

Publication number Publication date
EE200000321A (en) 2001-08-15
SE9704546D0 (en) 1997-12-05
AU1791599A (en) 1999-06-28
NO20002787D0 (en) 2000-05-31
CN1284074A (en) 2001-02-14
BR9813378A (en) 2000-10-10
TR200001544T2 (en) 2000-11-21
CA2312357A1 (en) 1999-06-17
NO20002787L (en) 2000-08-01
HUP0100731A2 (en) 2002-05-29
IL136368A0 (en) 2001-06-14
EP1037889A1 (en) 2000-09-27
WO1999029686A1 (en) 1999-06-17
HUP0100731A3 (en) 2002-08-28
KR20010032800A (en) 2001-04-25
SK8442000A3 (en) 2001-01-18
JP2001525406A (en) 2001-12-11

Similar Documents

Publication Publication Date Title
EG24412A (en) Novel compounds
GB9701684D0 (en) Novel compounds
GB9706255D0 (en) Novel compounds
GB9707830D0 (en) Novel compounds
GB9703492D0 (en) Novel compounds
GB9705619D0 (en) Novel compounds
GB9703493D0 (en) Novel compounds
GB9700688D0 (en) Novel compounds
GB9700689D0 (en) Novel compounds
GB9700694D0 (en) Novel compounds
GB9700901D0 (en) Novel compounds
GB9700902D0 (en) Novel compounds
GB9701597D0 (en) Novel compounds
GB9700591D0 (en) Novel compounds
GB9703011D0 (en) Novel compounds
GB9703333D0 (en) Novel compounds
GB9703334D0 (en) Novel compounds
GB9710735D0 (en) Novel compounds
GB9706937D0 (en) Novel compounds
GB9700590D0 (en) Novel compounds
GB9706827D0 (en) Novel compounds
GB9704461D0 (en) Novel compounds
GB9704462D0 (en) Novel compounds
GB9705385D0 (en) Novel compounds
GB9709520D0 (en) Novel compounds